Skip to main content
Clinical Trials/IRCT20220423054619N1
IRCT20220423054619N1RecruitingPhase 2

Comparison of the effectiveness of ? prescribing Fingolimod with Non-prescribing fingolimod in improving stroke related scales in Acute Ischemic Stroke(AIS) patients referring in 4.5 hours of symptoms onset

Tehran University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 80 years (—)
Sex
All

Inclusion Criteria

  • Acute onset focal neurologic deficit
  • Age more then 18 years
  • referring to hospital in less than 4.5 hours

Exclusion Criteria

  • Age more than 80
  • History of moderate or severe cardiovascular condition
  • History of prior probable retinal problems
  • Active viral or bacterial infection
  • Suspicion of other neurologic conditions than CVA
  • No existing hyperdense lesion in entry CT scan consisting with hemorrhagic lesion

Investigators

Similar Trials